Skip to main content
SpringerLink
Log in

T1G3 bladder cancer – Indications for early cystectomy

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objectives: To review our experience with early radical cystectomy in patients with T1G3 Transitional Cell Carcinoma of bladder (TCC). Patients and methods: Thirty patients, who underwent early radical cystectomy over a 10-year period for clinical stage T1G3 TCC bladder, were studied. Of these 21 (70%) had radical cystectomy without treatment with intravesical chemo/immunotherapy. The number of tumours, presence or absence of Carcinoma In-Situ (CIS) and the pathological stage of the cystectomy specimen were recorded in each patient. Disease specific survival was determined in the subgroups using Kaplan-Meier estimates. Results: Seventeen patients underwent radical surgery for a single tumour without concomitant CIS (Group A). The other 13 had multiple tumours with or without concomitant CIS or a single tumour with CIS (Group B). The disease was upstaged after cystectomy in 1 (6%) patient in Group A compared to 7 (55%) in Group B, (p = 0.009). Nine (53%) had pT0 disease in Group A compared to 0% in Group B, (p = 0.0017). The 5-year cancer specific survival rates were 92% in Group A and 82% in Group B. Conclusions: In patients with multiple T1G3 tumours with or without associated CIS, or in those with single T1G3 tumour with associated CIS the incidence of the disease being already muscle invasive at the time of clinical diagnosis is 55%. Early radical cystectomy should be advocated in this group. Conversely, for a single T1G3 tumour without associated CIS, conservative bladder preserving strategy with immuno-chemotherapy and close surveillance is justified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freeman JA, Esrig D, Stein JP et al. Radical cystectomy for high-risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995; 76: 833–839.

    Article  PubMed  CAS  Google Scholar 

  2. Stein JP. Indications for early cystectomy. Semin Urol Oncol 2000; 18: 289–295.

    PubMed  CAS  Google Scholar 

  3. Birch BRP, Harland SJ. The pT1G3 bladder tumour. Br J Urol 1989; 64: 109–111.

    PubMed  CAS  Google Scholar 

  4. Sriprasad SI, Hopster D, Muir GH et al. The biological characteristics of pT1G3 bladder tumours are the same as muscle invasive cancer: a study of cell proliferation and molecular markers of aggressiveness. J Urol 2001; 165(5): supplement 192.

    Google Scholar 

  5. Brake M, Loertzer H, Horsch R et al. Recurrence and progression of stage T1, Grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with Bacillus Calmette-Guerin. J Urol 2000; 163: 1697–1701.

    Article  PubMed  CAS  Google Scholar 

  6. Cookson MS, Herr HW, Zhang ZF et al. The treated natural history of high risk superficial bladder cancer: 15 year outcome J Urol 1997; 158: 62–66.

    Article  PubMed  CAS  Google Scholar 

  7. Montie JE, Wood DP Jr. The risk of radical cystectomy. Br J Urol 1989; 63: 483–486.

    PubMed  CAS  Google Scholar 

  8. Rosario DJ, Becker M, Anderson JB. The changing pattern of mortality and morbidity from radical cystectomy. BJU Int 2000; 85: 427–430.

    Article  PubMed  CAS  Google Scholar 

  9. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. Jr Clin Oncol 2001; 19: 666–675.

    CAS  Google Scholar 

  10. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A. Results of contemporary radical cystectomy for invasive bladder cancer: a clinico-pathologic study with emphasis on the inadequacy of the tumour, node and metastasis classification. J Urol 1991; 145: 45–50.

    PubMed  CAS  Google Scholar 

  11. Malkowicz SB, Nichols P, Lieskovsky G et al. The role of radical cystectomy in the management of high grade superficial bladder cancer (Pa, P1, PIS and P2). J Urol 1990; 144: 641–644.

    PubMed  CAS  Google Scholar 

  12. Amling CL, Thrasher JB, Frazier HA et al. Radical Cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 1994; 151: 31–36.

    PubMed  CAS  Google Scholar 

  13. Stockle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R. Radical cystectomy – often too late Eur Urol 1987; 13: 361–367.

    PubMed  CAS  Google Scholar 

  14. Sobin LH, Wittekind Ch, eds. TNM Classification of Malignant Tumours, 6th edn. New York: Wiley, 2002.

    Google Scholar 

  15. Lamm DL, Blumenstein BA, Crissman JD et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1, and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study J Urol 2000; 163: 1124–1129.

    Article  PubMed  CAS  Google Scholar 

  16. Herr HW, Schwalb DM, Zhang ZF et al. Intravesical bacillus Calmette-Guerin therapy prevent tumour progression and death from superficial bladder cancer: ten year follow-up of a prospective randomized trial. J Clin Oncol 1995; 13: 1404–1408.

    PubMed  CAS  Google Scholar 

  17. Abel PD, Hall RR, Williams G. Should pT1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol 1988; 62: 235.

    PubMed  CAS  Google Scholar 

  18. Herr HW. Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 1997; 80: 762–765.

    PubMed  CAS  Google Scholar 

  19. Vicente MP, Laguna D, Duarte F et al. Carcinoma in Situ as a prognostic factor for G3 pT1 bladder tumours. Br J Urol 1991; 68: 380–382.

    Article  PubMed  CAS  Google Scholar 

  20. Mufti GR, Virdi, JS, Hall MH. Long-term follow-up of intravesical epodyl therapy for superficial bladder cancer. Br J Urol 1990; 65: 32–35.

    PubMed  CAS  Google Scholar 

  21. Dalbagni G, Genega E, Hashibe M et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001; 165: 1111–1116.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Medway Maritime Hospital, Windmill Road, Gillingham, Kent, ME7 5NY, UK

    S. Masood, S. Sriprasad, J.H. Palmer & G.R. Mufti

Authors
  1. S. Masood
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sriprasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.H. Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G.R. Mufti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G.R. Mufti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masood, S., Sriprasad, S., Palmer, J. et al. T1G3 bladder cancer – Indications for early cystectomy. Int Urol Nephrol 36, 41–44 (2003). https://doi.org/10.1023/B:UROL.0000032688.37789.7c

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:UROL.0000032688.37789.7c

Search

Navigation